Li Shanshan, Jiao Gege, Ou Penghui, Zhang Xiaona, Yu Yang, Wang Yihui, Yao Qingping, Wang Wei
School of Perfume & Aroma and Cosmetics, Shanghai Institute of Technology, Shanghai 201418, China.
Institute of Mechanobiology & Medical Engineering, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China.
Plants (Basel). 2025 Jun 5;14(11):1725. doi: 10.3390/plants14111725.
The flower buds of Pamp. (MBP), one of the botanical sources of (), are widely used in traditional medicine; however, their potential role in melanoma treatment remains unexplored. In this study, the phytochemical composition, antioxidant activity, and anti-melanoma mechanisms of MBP extracts were systematically investigated. Phytochemical profiling using UHPLC-Q-Exactive Orbitrap MS identified 26 bioactive compounds. The ethanol extract exhibited high total flavonoid and polyphenol contents, correlating with enhanced antioxidant capacity as demonstrated by DPPH and ABTS assays. Network pharmacology analysis highlighted the JAK/STAT signaling pathway, identifying STAT3 and STAT1 as core targets. Western blot analysis confirmed MBP significantly inhibited the phosphorylation of JAK1 and STAT1 in melanoma cells. Connectivity Map (CMap) and network analyses further pinpointed naringenin as a primary active constituent. In vitro assays demonstrated that MBP and naringenin inhibited the proliferation and migration of A375 and B16F10 melanoma cells, while exhibiting relatively low cytotoxicity toward normal keratinocytes. Molecular docking and dynamics simulations revealed strong and stable binding interactions between naringenin and JAK1/STAT1 proteins. These findings collectively support MBP and naringenin as promising candidates for melanoma treatment, providing mechanistic evidence for their targeted activity and laying a foundation for future research and clinical applications.
Pamp.(MBP)的花芽是()的植物来源之一,在传统医学中广泛应用;然而,其在黑色素瘤治疗中的潜在作用仍未得到探索。在本研究中,对MBP提取物的植物化学成分、抗氧化活性和抗黑色素瘤机制进行了系统研究。使用UHPLC-Q-Exactive Orbitrap MS进行的植物化学分析鉴定出26种生物活性化合物。乙醇提取物表现出较高的总黄酮和多酚含量,DPPH和ABTS分析表明其抗氧化能力增强。网络药理学分析突出了JAK/STAT信号通路,确定STAT3和STAT1为核心靶点。蛋白质印迹分析证实MBP显著抑制黑色素瘤细胞中JAK1和STAT1的磷酸化。连通性图谱(CMap)和网络分析进一步确定柚皮素为主要活性成分。体外试验表明,MBP和柚皮素抑制A375和B16F10黑色素瘤细胞的增殖和迁移,而对正常角质形成细胞的细胞毒性相对较低。分子对接和动力学模拟揭示了柚皮素与JAK1/STAT1蛋白之间强烈且稳定的结合相互作用。这些发现共同支持MBP和柚皮素作为黑色素瘤治疗的有前景的候选物,为其靶向活性提供了机制证据,并为未来的研究和临床应用奠定了基础。